Trump's Executive Order Aims to Slash Prescription Drug Prices

President Trump announced a new executive order on May 12th, 2025, aiming to drastically reduce prescription drug prices in the United States. This move follows concerns about the high cost of medications in the US compared to other developed nations. The order doesn't specify target drugs, but officials suggest GLP-1s will likely be included. In a statement at the White House, President Trump said, "We are going to pay the lowest price there is in the world." This initiative could significantly impact healthcare costs and access for millions of Americans, potentially leading to both positive and negative consequences depending on the specific implementation details. The long-term effects on pharmaceutical companies and the healthcare system remain to be seen. This bold move has the potential to reshape the landscape of prescription drug pricing in the US.